• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

MIT researchers developing device to pump drugs to the brain

August 11, 2017 By Sarah Faulkner

MIT brain drug pump
Credit: Denis Paiste/Materials Processing Center

Researchers at the Massachusetts Institute of Technology are developing a pump to deliver drugs directly to the brain.

Alejandro Aponte, a mechanical engineering major at the University of Puerto Rico, has spent his summer working with Michael Cima, a professor of engineering, as part of MIT’s Summer Scholars program.

The team’s pump prototype is attached to a needle, enabling targeted drug delivery. Aponte has focused his efforts on keeping the pump’s multiple parts as static as possible.

““That will be really important for when we want to make these smaller and implantable, because not only do we not want movement of the needle, but we also don’t want moving of this central actuation portion,” MIT postdoc Ritu Raman told MIT News.

To optimize the pump’s design, Aponte started with a modular version made up of many parts and moved to an integrated design.

“That’s actually very important for when we’re building prototypes,” Raman said. “We want to take apart every little piece and think about how can we make this part better and that better, and then at the end, we can put it all together.”

At the heart of the team’s design strategy is an attempt to make the drug pump as small as possible.

“This is very important because the type of work that we are doing requires the pump to be implantable, so that’s our main target here,” Aponte said.

The lab hopes that eventually their technology could be used to diagnose and treat brain disorders, like anxiety and depression.

“The critical part of this platform is we have these probes that go into very specific neural circuits inside the brain and we want to infuse drugs to those circuits,” Raman said, according to the news outlet.

See the best minds in medtech live at DeviceTalks Boston on Oct. 2.

Filed Under: Drug-Device Combinations, Featured, Neurological, Pharmaceuticals, Research & Development Tagged With: Massachusetts Institute of Technology

IN CASE YOU MISSED IT

  • Glooko adds chief strategy officer to chief medical officer’s title
  • Cordis launches 10,000-patient registry for drug-eluting balloon
  • Senseonics opens $50M public offering, $25M private placement with Abbott
  • Study links Abbott CGM use to lower risk of hospitalizations due to heart complications
  • Go-Pen ApS wins FDA nod for user-filled insulin pen

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS